FANIN, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 5.578
EU - Europa 793
AS - Asia 785
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
SA - Sud America 2
Totale 7.165
Nazione #
US - Stati Uniti d'America 5.570
CN - Cina 392
SG - Singapore 252
SE - Svezia 170
FI - Finlandia 148
DE - Germania 110
VN - Vietnam 110
UA - Ucraina 94
IT - Italia 72
GB - Regno Unito 70
FR - Francia 69
NL - Olanda 21
HK - Hong Kong 16
IE - Irlanda 11
IN - India 11
RU - Federazione Russa 10
CA - Canada 7
GR - Grecia 6
BE - Belgio 5
EU - Europa 4
AU - Australia 3
BR - Brasile 2
ES - Italia 2
SK - Slovacchia (Repubblica Slovacca) 2
CH - Svizzera 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
PA - Panama 1
RO - Romania 1
TR - Turchia 1
TW - Taiwan 1
Totale 7.165
Città #
Fairfield 707
Chandler 581
Jacksonville 484
Ann Arbor 472
Woodbridge 472
Houston 400
Wilmington 316
Ashburn 295
Cambridge 243
Seattle 232
Singapore 195
Princeton 157
Boardman 149
Dong Ket 109
Beijing 101
Roxbury 93
Santa Clara 93
San Diego 75
Des Moines 67
Medford 61
Nanjing 51
Guangzhou 50
Helsinki 50
New York 26
Hebei 23
Shenyang 21
Norwalk 18
Hong Kong 16
Jiaxing 16
Padova 16
Nanchang 14
Redwood City 14
Charlottesville 13
Munich 12
Changsha 11
Shanghai 11
Tianjin 11
Menlo Park 10
Dublin 8
Jinan 8
Milan 7
Columbus 6
Las Vegas 6
Kharkiv 5
London 5
Los Angeles 5
Ogden 5
Kilburn 4
Mountain View 4
Rockville 4
Tappahannock 4
Waanrode 4
Borås 3
Chicago 3
Detroit 3
Falls Church 3
Haikou 3
Indiana 3
Mcallen 3
Ningbo 3
North York 3
San Giuseppe Vesuviano 3
San Jose 3
Acton 2
Barcelona 2
Borgosatollo 2
Dallas 2
Gassino Torinese 2
Hefei 2
Lanzhou 2
Monmouth Junction 2
Montréal 2
Nizna 2
Nuremberg 2
Nürnberg 2
Phoenix 2
Portland 2
Simi Valley 2
Stella Cilento 2
São Paulo 2
Washington 2
Yellow Springs 2
Zhengzhou 2
Alghero 1
Anaheim 1
Ardabil 1
Atlanta 1
Babraham 1
Barstow 1
Basking Ridge 1
Boston 1
Bristol 1
Budapest 1
Changteh 1
Chengdu 1
Chiswick 1
Clifton 1
Curtarolo 1
Edinburgh 1
Espoo 1
Totale 5.850
Nome #
Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies 152
Cardioembolic stroke in Danon disease. 141
Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy 140
Progress in enzyme replacement therapy in glycogen storage disease type II 140
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 140
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 135
Autophagy dysregulation in Danon disease 125
Acute quadriplegic myopathy in a 17 month old boy 120
Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes 118
Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease 115
Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1 113
Study of Muscle Autophagy and Atrophy Markers in Different Phenotypes of Pompe Disease 113
Prevalence of dystrophin-positive fibers in 85 duchenne muscular dystrophy patients 110
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 107
Heart transplantation in patients with Inherited myopathies associated with end-stage cardiomyopathy: molecular and biochemical defects on cardiac and skeletal muscle 107
Gene expression profiling in dysferlinopathies using a dedicated muscle microarray 101
Sphingomonas paucimobilis associated with localised calf myositis 100
Dystrophin-positive fibers in duchenne dystrophy: Origin and correlation to clinical course 99
Heart involvement in muscular dystrophies due to sarcoglycan gene mutations 98
Cardiac involvement in Becker muscular dystrophy 97
LGMD2E patients risk developing dilated cardiomyopathy 95
Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2) 92
Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents 91
The genetic basis of undiagnosed muscular dystrophies and myopathies 91
Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D. 91
Peculiar association of a vacuolar myopathy with multiple sclerosis. 90
Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: characterization of sub-clinical phenotypes. 90
Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. 89
Prognostic factors in mild dystrophinopathies. 89
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript 89
Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR 88
Adult acid maltase deficiency: an open trial with albuterol and branched- chain aminoacids 88
Phenotype modulators in myophosphorylase deficiency 85
The role of ultrastructural examination in storage diseases 83
A novel laminin alpha2 isoform in severe laminin alpha2 deficient congenital muscular dystrophy. 81
Absence of dystrophin and spectrin in regenerating muscle fibers from Becker dystrophy patients. 81
Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy 81
Application of a cDNA microarray for the analysis of muscular dystrophies and childhood leukemias 81
Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan 80
A severe case of Duchenne-like muscular dystrophy due to a mutation in the alpha-sarcoglycan (adhalin) gene 79
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 75
Hypertrophic cardiomyopathy with mitochondrial myopathy. A new phenotype of complex II defect. 75
Multisystem primary defect of LAMP-2 in Danon disease 74
Mutations in the sarcoglycan genes in patients with myopathy. 72
Laminin alpha 2 muscular dystrophy: genotype/phenotype study in 22 patients 71
Multisystemic LAMP-2 defect in Danon disease. 71
Biochemical and ultrastructural evidence of endoplasmic reticulum stress in LGMD2I 71
Investigating the mechanism of chromosomal deletion: Characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene 71
Cardiomyopathy in b-sarcoglycanopathies: a new pathogenetic hypothesis 67
Molecular diagnosis in LGMD2A: Mutation analysis or protein testing? 67
Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression 66
Gene expression profiling in skeletal muscle using a dedicated microarray 66
Integrin alpha 7 beta 1 in muscular dystrophy/myopathy of unknown etiology 65
Cardiac transplantation in a Duchenne muscular dystrophy carrier 63
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy. 62
Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiency 62
null 61
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 61
11-year clinical follow-up of a patient with dysferlinopathy-report on the first diagnosed slovenian case 61
Does sport affect LGMD2B progression? 60
Enormous dystrophin in a patient with becker muscular dystrophy 58
Muscle atrophy in Limb Girdle Muscular Dystrophy 2A: A morphometric and molecular study 58
Muscle fiber regeneration in Dystrophies and Neurogenic Atrophies. 57
Limb-girdle muscular dystrophy type 1: anticipation or epigenetic modifications? 54
Regeneration in muscular dystrophies: a review and immunohistochemical study. 53
Fetal Myosin Heavy Chain (FMHC) and Vimentin (VM) as markers of muscle regeneration in neurogenic disorders. 52
Immunohistochemical analyses in human muscular dystrophies. 50
MRI study of limb girdle muscular dystrophies and inflammatory myopathies. 50
Dysferlin and calpain deficiency: combined screening in 370 myopathy patients 50
Ultrastructural and histopathological studies in limb girdle 2I. 49
Prenatal diagnosis in beta-sarcoglycan muscular dystrophy. 49
Miopatie congenite 48
Clinical heterogeneity in limb-girdle muscular dystrophy type 2I 48
Missplicing of Troponin T transcripts in Myotonic dystrophy type 2 human biopsies 48
Novel sarcoglycan gene mutation in a large cohort of Italian patients 47
INHIBITION OF PROTEASOME ACTIVITY PROMOTES THE CORRECT LOCALIZATION OF DESEASE-CAUSING ALPHA-SARCOGLYCAN MUTANTS IN A HETEROLOGOUS CELL SYSTEM EXPRESSING BETA-, GAMMA-, AND DELTA-SARCOGLYCAN 46
Beta-sarcoglycan gene mutations cause plasma membrane dysruption in striated and smooth muscle, leading to severe dilated cardiomyopathy 44
Myocardial involvement is very frequent among patients affected with subclinical muscular dystrophy 44
Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism 43
The frequency of limb girdle muscular dystrophy 2A in northeastern Italy 43
Muscle damage after hyperthermic isolated limb perfusion: does doxorubicin induce desminopathy? 43
Private beta- and gamma- sarcoglycan gene mutations: evidence of a founder effect in Northern Italy 43
Novel sarcoglycan mutations widen the clinical spectrum of limb girdle muscular dystrophy 2C, 2D, 2E, 2F 43
La rigenerazione muscolare nelle distrofie 43
Diagnosis and treatment of cardiac involvement in Becker muscular dystrophy 41
alpha-Sarcoglycan (adhalin) deficiency: complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations. 40
Muscle atrophy in Limb Girdle Muscular Dystrophy 2A: A morphometric and molecular study 40
Diagnosis and therapy of myophosphorylase deficiency: experience with a group of italian patients 39
CTG repeat expansion and fiber type composition affect DMPK expression in myotonic dystrophy type 1. 38
Study of atrophy factors in 7 patients with myotonic dystrophy type 2 34
Genetic and clinical-pathological findings in limb girdle muscular dystrophy type 2I 34
Dysferlinopathy: correlation between expression profilino and pathological changes 33
Cuore e malattie neuromuscolari 32
FKRP mutation study in muscular dystrophy of unknown etiology 31
Cuore, malattie neuromuscolari e malattie del sistema nervoso 30
Could utrophin rescue the myocardium of pateints with dystrophin gene mutations? 28
Integrin alpha 7beta1 in muscular dystrophy/myopathy of unknown etiology 25
Sarcoglycanopathy phenotype includes hyperckemia, severe or mild limb-girdle dystrophy and cardiomyopathy 23
Laminin alpha2 negative congenital muscular dystrophy (MDC1A) presenting with a mild phenotype 22
Le distrofie muscolari dei cingoli (LGMD) 21
Totale 7.120
Categoria #
all - tutte 25.835
article - articoli 21.181
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 764
Totale 47.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020687 0 0 0 0 0 0 95 140 108 178 89 77
2020/20211.038 24 87 24 180 50 86 18 107 136 72 108 146
2021/20221.336 49 163 138 166 47 123 44 120 44 21 141 280
2022/20231.073 229 118 18 146 142 170 5 69 115 10 46 5
2023/2024391 18 61 51 32 13 33 14 10 20 41 43 55
2024/2025600 1 97 110 70 278 44 0 0 0 0 0 0
Totale 7.196